• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一家儿科医院对 AAP 临床实践指南中发热婴儿的应用情况。

Performance of AAP Clinical Practice Guideline for Febrile Infants at One Pediatric Hospital.

机构信息

Departments of Pediatrics.

University of Rochester Medical Center, Department of Public Health Sciences, Rochester, New York.

出版信息

Hosp Pediatr. 2023 Mar 1;13(3):e47-e50. doi: 10.1542/hpeds.2022-006820.

DOI:10.1542/hpeds.2022-006820
PMID:36727277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986852/
Abstract

BACKGROUND

In the absence of procalcitonin, the American Academy of Pediatrics' clinical practice guideline (CPG) for evaluating and managing febrile infants recommends using previously untested combinations of inflammatory marker thresholds. Thus, CPG performance in detecting invasive bacterial infections (IBIs; bacteremia, bacterial meningitis) is poorly understood.

OBJECTIVE

To evaluate CPG performance without procalcitonin in detecting IBIs in well-appearing febrile infants 8 to 60 days old.

METHODS

For this cross-sectional, single-site study, we manually abstracted data for febrile infants using electronic health records from 2011 to 2018. We used CPG inclusion/exclusion criteria to identify eligible infants and stratified IBI risk with CPG inflammatory marker thresholds for temperature, absolute neutrophil count, and C-reactive protein. Because the CPG permits a wide array of interpretations, we performed 3 sensitivity analyses, modifying age and inflammatory marker thresholds. For each approach, we calculated area-under-the-receiver operating characteristic curve, sensitivity, and specificity in detecting IBIs.

RESULTS

For this study, 507 infants met the inclusion criteria. For the main analysis, we observed an area-under-the-receiver operating characteristic curve of 0.673 (95% confidence interval 0.652-0.694), sensitivity of 100% (66.4%-100%), and specificity of 34.5% (30.4%-38.9%). For the sensitivity analyses, sensitivities were all 100% and specificities ranged from 9% to 38%.

CONCLUSION

Findings suggest that the CPG is highly sensitive, minimizing missed IBIs, but specificity may be lower than previously reported. Future studies should prospectively investigate CPG performance in larger, multisite samples.

摘要

背景

在美国儿科学会(AAP)评估和管理发热婴儿的临床实践指南(CPG)缺乏降钙素原的情况下,建议使用以前未经测试的炎症标志物阈值组合。因此,CPG 在检测侵袭性细菌性感染(IBI;菌血症、细菌性脑膜炎)方面的性能尚不清楚。

目的

评估无降钙素原时 CPG 在检测 8 至 60 天龄外观良好的发热婴儿中的 IBI 的性能。

方法

在这项横断面、单站点研究中,我们使用电子健康记录从 2011 年至 2018 年手动提取发热婴儿的数据。我们使用 CPG 的纳入/排除标准来识别合格的婴儿,并根据 CPG 炎症标志物阈值对体温、绝对中性粒细胞计数和 C 反应蛋白进行 IBI 风险分层。由于 CPG 允许广泛的解释,我们进行了 3 项敏感性分析,修改了年龄和炎症标志物阈值。对于每种方法,我们计算了检测 IBI 的受试者工作特征曲线下面积、敏感性和特异性。

结果

这项研究共纳入了 507 名婴儿。在主要分析中,我们观察到受试者工作特征曲线下面积为 0.673(95%置信区间 0.652-0.694),敏感性为 100%(66.4%-100%),特异性为 34.5%(30.4%-38.9%)。在敏感性分析中,敏感性均为 100%,特异性范围为 9%至 38%。

结论

这些发现表明,CPG 具有很高的敏感性,最大限度地减少了漏诊的 IBI,但特异性可能低于先前报道。未来的研究应前瞻性地在更大、多站点的样本中调查 CPG 的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516b/9986852/92012bd55a72/HPEDS_2022006820fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516b/9986852/92012bd55a72/HPEDS_2022006820fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516b/9986852/92012bd55a72/HPEDS_2022006820fig01.jpg

相似文献

1
Performance of AAP Clinical Practice Guideline for Febrile Infants at One Pediatric Hospital.一家儿科医院对 AAP 临床实践指南中发热婴儿的应用情况。
Hosp Pediatr. 2023 Mar 1;13(3):e47-e50. doi: 10.1542/hpeds.2022-006820.
2
Using AAP Guidelines for Managing Febrile Infants Without C-Reactive Protein and Procalcitonin.使用美国儿科学会管理无C反应蛋白和降钙素原的发热婴儿的指南。
Pediatrics. 2023 Jan 1;151(1). doi: 10.1542/peds.2022-058495.
3
Derivation of a clinical-based model to detect invasive bacterial infections in febrile infants.基于临床的发热婴儿侵袭性细菌感染检测模型的建立。
J Hosp Med. 2022 Nov;17(11):893-900. doi: 10.1002/jhm.12956. Epub 2022 Aug 29.
4
Validation and comparison of the PECARN rule, Step-by-Step approach and Lab-score for predicting serious and invasive bacterial infections in young febrile infants.PECARN 规则、分步评估法和实验室评分对预测发热婴幼儿严重及侵袭性细菌感染的验证与比较。
Ann Acad Med Singap. 2022 Oct;51(10):595-604. doi: 10.47102/annals-acadmedsg.2022193.
5
Performance of Febrile Infant Decision Tools on Hypothermic Infants Evaluated for Infection.发热婴儿决策工具在评估感染性低体温婴儿中的表现。
Hosp Pediatr. 2024 Mar 1;14(3):163-171. doi: 10.1542/hpeds.2023-007525.
6
Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections.全血细胞计数用于识别60日龄及以下发热婴儿侵袭性细菌感染的准确性。
JAMA Pediatr. 2017 Nov 6;171(11):e172927. doi: 10.1001/jamapediatrics.2017.2927.
7
Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.降钙素原检测在预测小儿发热中严重细菌感染的应用。
JAMA Pediatr. 2016 Jan;170(1):62-9. doi: 10.1001/jamapediatrics.2015.3210.
8
Lack of Accuracy of Biomarkers and Physical Examination to Detect Bacterial Infection in Febrile Infants.生物标志物和体格检查在检测发热婴儿细菌感染方面缺乏准确性。
Pediatr Emerg Care. 2016 Oct;32(10):664-668. doi: 10.1097/PEC.0000000000000401.
9
A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections.一种用于识别 60 天及以下发热婴儿中患有严重细菌感染低风险的临床预测规则。
JAMA Pediatr. 2019 Apr 1;173(4):342-351. doi: 10.1001/jamapediatrics.2018.5501.
10
Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.降钙素原在儿科急诊科用于发热婴儿侵袭性细菌感染的早期诊断:一项多中心研究结果及该标志物快速定性检测的效用
Pediatr Infect Dis J. 2003 Oct;22(10):895-903. doi: 10.1097/01.inf.0000091360.11784.21.

引用本文的文献

1
Development of a machine learning-based prediction model for serious bacterial infections in febrile young infants.基于机器学习的发热小婴儿严重细菌感染预测模型的开发。
BMJ Paediatr Open. 2025 Jul 30;9(1):e003548. doi: 10.1136/bmjpo-2025-003548.
2
Scoping review of clinical decision aids in the assessment and management of febrile infants under 90 days of age.90日龄以下发热婴儿评估与管理中临床决策辅助工具的范围综述
BMC Pediatr. 2025 Apr 4;25(1):274. doi: 10.1186/s12887-025-05619-3.
3
External Validation of Brief Resolved Unexplained Events Prediction Rules for Serious Underlying Diagnosis.

本文引用的文献

1
Guideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement.未进行降钙素原检测的发热小婴儿基于指南的风险分层
Pediatrics. 2022 Jun 1;149(6). doi: 10.1542/peds.2021-056028.
2
Refinement and Validation of a Clinical-Based Approach to Evaluate Young Febrile Infants.基于临床的评估方法对发热婴儿的细化与验证。
Hosp Pediatr. 2022 Apr 1;12(4):399-407. doi: 10.1542/hpeds.2021-006214.
3
Clinical Guideline Synopsis of Evaluation and Management of Well-Appearing Febrile Infants Aged 8 to 60 Days.8至60日龄一般状况良好的发热婴儿评估与管理临床指南概要
严重潜在诊断的短暂不明原因事件预测规则的外部验证
JAMA Pediatr. 2025 Feb 1;179(2):188-196. doi: 10.1001/jamapediatrics.2024.4399.
4
Performance of AAP CPG for Ineligible Well-Appearing Febrile Infants Aged 8-60 Days.不适合 AAP CPG 的表现 8-60 天外观良好发热婴儿。
Hosp Pediatr. 2024 Dec 1;14(12):e509-e512. doi: 10.1542/hpeds.2023-007458.
JAMA Pediatr. 2022 Jun 1;176(6):602-603. doi: 10.1001/jamapediatrics.2022.0066.
4
Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old.8 至 60 日龄外观健康发热婴儿的评估和管理。
Pediatrics. 2021 Aug;148(2). doi: 10.1542/peds.2021-052228. Epub 2021 Jul 19.
5
External Validation of an Invasive Bacterial Infection Score for Young Febrile Infants.对发热婴儿侵袭性细菌感染评分的外部验证。
Hosp Pediatr. 2021 Mar;11(3):239-244. doi: 10.1542/hpeds.2020-003178.
6
Using Clinical History Factors to Identify Bacterial Infections in Young Febrile Infants.利用临床病史因素识别发热婴儿中的细菌感染。
J Pediatr. 2021 May;232:192-199.e2. doi: 10.1016/j.jpeds.2020.12.079. Epub 2021 Jan 7.
7
Accuracy of PECARN rule for predicting serious bacterial infection in infants with fever without a source.PECARN 规则预测无明确病因发热婴儿严重细菌感染的准确性。
Arch Dis Child. 2021 Feb;106(2):143-148. doi: 10.1136/archdischild-2020-318882. Epub 2020 Aug 19.
8
Time to Pathogen Detection for Non-ill Versus Ill-Appearing Infants ≤60 Days Old With Bacteremia and Meningitis.60日龄以内患菌血症和脑膜炎的无病症与有病症婴儿的病原体检测时间
Hosp Pediatr. 2018 Jul;8(7):379-384. doi: 10.1542/hpeds.2018-0002.
9
Procalcitonin Test Availability: A Survey of Acute Care Hospitals in Massachusetts.降钙素原检测的可及性:马萨诸塞州急症医院的一项调查
Ann Am Thorac Soc. 2017 Sep;14(9):1489-1491. doi: 10.1513/AnnalsATS.201704-306RL.
10
Validation of the "Step-by-Step" Approach in the Management of Young Febrile Infants.“逐步”方法在幼儿发热管理中的验证
Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2015-4381. Epub 2016 Jul 5.